Related references
Note: Only part of the references are listed.Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Tateaki Naito et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer
John D. O'Flaherty et al.
LUNG CANCER (2012)
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Cristina Raimondi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
Michal Mego et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
Stephen D. Mikolajczyk et al.
JOURNAL OF ONCOLOGY (2011)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study
I. Boukovinas et al.
LUNG CANCER (2009)
Variation of circulating tumor cell levels during treatment of metastatic breast cancer:: prognostic and therapeutic implications
F. Nole et al.
ANNALS OF ONCOLOGY (2008)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: The Hellenic Oncology Research Group experience
Athanasios G. Pallis et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
Vassilis Georgoulias et al.
LUNG CANCER (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer
Jingwei Jiang et al.
LUNG CANCER (2007)
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
Franco Berrino et al.
LANCET ONCOLOGY (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer
G. Thomas Budd et al.
CLINICAL CANCER RESEARCH (2006)
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
V Georgoulias et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Gemcitabine-docetaxel versus cisplatin.-vinorelbine in advanced or metastatic non-small-cell lung cancer:: a phase III study addressing the case for cisplatin
JL Pujol et al.
ANNALS OF ONCOLOGY (2005)
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730)
RC Lilenbaum et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
C Gridelli et al.
ANNALS OF ONCOLOGY (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood
R Rosenberg et al.
CYTOMETRY (2002)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
